Stockreport

Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF Gross Margin: Approximately 93% for the third quarter. Gross to Net Discount: Approximately 40%, with an adjustment leading to a reduction of about 3% or $2 million. [Read more]